GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » LungLife AI Inc (LSE:LLAI) » Definitions » Additional Paid-In Capital

LungLife AI (LSE:LLAI) Additional Paid-In Capital : £72.10 Mil(As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is LungLife AI Additional Paid-In Capital?


LungLife AI's quarterly additional paid-in capital declined from Dec. 2022 (£74.93 Mil) to Jun. 2023 (£72.28 Mil) but then stayed the same from Jun. 2023 (£72.28 Mil) to Dec. 2023 (£72.10 Mil).

LungLife AI's annual additional paid-in capital increased from Dec. 2021 (£68.63 Mil) to Dec. 2022 (£74.93 Mil) but then declined from Dec. 2022 (£74.93 Mil) to Dec. 2023 (£72.10 Mil).


LungLife AI Additional Paid-In Capital Historical Data

The historical data trend for LungLife AI's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LungLife AI Additional Paid-In Capital Chart

LungLife AI Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial 39.76 38.83 68.63 74.93 72.10

LungLife AI Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only 68.63 74.11 74.93 72.28 72.10

LungLife AI Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

LungLife AI Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of LungLife AI's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


LungLife AI (LSE:LLAI) Business Description

Traded in Other Exchanges
N/A
Address
2545 W. Hillcrest Drive, Suite 140, Thousand Oaks, CA, USA, 91320
LungLife AI Inc is a diagnostic company focused on the early detection of lung cancer from a simple blood draw enhanced by artificial intelligence. Its LungLB Test is a blood-based tool developed to provide clinicians the information needed to make informed decisions about the management of lung nodules and lung cancer.

LungLife AI (LSE:LLAI) Headlines

No Headlines